Author:
Sakuraba Hitoshi,Togawa Tadayasu,Tsukimura Takahiro,Kato Hiroshi
Funder
Dainippon Sumitomo Pharma
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Nephrology,Physiology
Reference14 articles.
1. Germain DP. Fabry disease. Orphanet J Rare Dis. 2010;5:30.
2. Cox TM. Biomarkers in lysosomal storage disease. In: Mehta A, Beck M, Sunder Plassman G, editors. Fabry disease: perspective from 5 years of FOS. Oxford: Oxford PharmaGenesis. 2006;pp. 75–91.
3. Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, et al. Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci USA. 2008;105:2812–7.
4. Rombach SM, Dekker N, Bouwman MG, Linthorst GE, Zwinderman AH, Wijburg FA, et al. Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease. Biochim Biophys Acta. 2010;1802:741–8.
5. Togawa T, Kodama T, Suzuki T, Sugawara K, Tsukimura T, Ohashi T, et al. Plasma globotriaosylsphingosine as a biomarker of Fabry disease. Mol Genet Metab. 2010;100:257 – 61.
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献